dobutamine has been researched along with ascorbic acid in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mak, S; Newton, GE | 2 |
Mak, S; Newton, GE; Overgaard, CB | 1 |
Hata, K; Hirata, K; Inoue, N; Masai, H; Matsumoto, D; Matsumoto, H; Otake, H; Ozawa, T; Shinke, T; Shite, J; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R | 1 |
Ragaller, M | 1 |
Almsherqi, Z; Deng, Y; Matthews, S; McLachlan, CS; Mossop, P | 1 |
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
3 review(s) available for dobutamine and ascorbic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Microcirculation in sepsis and septic shock - therapeutic options?].
Topics: Ascorbic Acid; Dobutamine; Germany; Humans; Microcirculation; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Vasculitis; Vasodilator Agents | 2008 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
2 trial(s) available for dobutamine and ascorbic acid
Article | Year |
---|---|
Vitamin C augments the inotropic response to dobutamine in humans with normal left ventricular function.
Topics: Adrenergic beta-Agonists; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Dobutamine; Drug Synergism; Female; Hemodynamics; Humans; Hypertension; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Ventricular Function, Left | 2001 |
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
5 other study(ies) available for dobutamine and ascorbic acid
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; History, Early Modern 1451-1600; Humans; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Reference Values; Ventricular Dysfunction, Left | 2004 |
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reactive Oxygen Species; Thermodilution; Ventricular Function, Left | 2007 |
Vitamin C and mitochondrial uncoupling protein in enhanced dobutamine myocardial contractility.
Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Humans; Mitochondria; Myocardial Contraction; Reactive Oxygen Species; Up-Regulation | 2008 |